Teladoc Health Inc buy Royal Bank of Canada
Start price
21.02.24
/
50%
€14.32
Target price
21.02.25
€23.12
Performance (%)
-17.12%
Price
03.05.24
€11.87
Summary
This prediction is currently active. The prediction for Teladoc Health Inc disappoints with a performance of -17.12%. This prediction currently runs until 21.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Teladoc Health Inc | -2.353% | -2.353% |
iShares Core DAX® | -0.922% | -1.993% |
iShares Nasdaq 100 | 0.371% | -0.868% |
iShares Nikkei 225® | 2.224% | -5.187% |
iShares S&P 500 | -0.026% | -0.918% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Teladoc Health Inc diskutieren
Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Royal Bank of Canada from $30.00 to $25.00. They now have an "outperform" rating on the stock.
Ratings data for TDOC provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Teladoc Health Inc
Teladoc Health Inc
Start price
Target price
Perf. (%)
€12.29
26.04.24
26.04.24
€16.82
26.04.25
26.04.25
-3.43%
03.05.24
03.05.24
Teladoc Health Inc
Start price
Target price
Perf. (%)
€16.46
25.10.23
25.10.23
€28.38
25.10.24
25.10.24
-27.90%
03.05.24
03.05.24